Mass Spectrometry in Biomarker Research to Exceed $745 Million by 2010

New York, November 16, 2006 — In the rapidly advancing world of biotechnology instrumentation, mass spectrometry (MS) has shown the necessary abilities to rapidly identify a variety of biochemicals, making it a workhorse for discovering and validating biomarkers in clinical research related to drug development and diagnostic applications. As such, MS has found a decisive home in protein biomarker applications, creating its own market currently worth $290 million, and estimated to grow at a rapid pace to upwards of $745 million by 2010.

According to Mass Spectrometry for Protein Biomarker Applications, the latest market research from Kalorama Information, the MS technologies used in biomarker discovery and validation applications far outperform any alternatives for this purpose, and the ever-increasing abilities of MS in protein science have drawn large numbers of researchers to procure MS instruments or use available core lab facilities for proteomics experiments.

Pursuing this opportunity, numerous companies are offering MS tools, services, and software relating specifically to discovery, validation, or clinical research of protein biomarkers. Revenues for services are expected to soar at a phenomenal compound annual growth rate of 18% from 2001 to 2011. In similar fashion, the report finds that the market for MS software for biomarker research is expected to grow at nearly the same rate, making these two sectors extremely promising focus areas in the overall MS marketplace.

“Protein biomarkers are helping to revolutionize modern medicine by allowing much earlier diagnosis of disease, providing ongoing information on patients’ responses to therapies, and/or predicting likely conditions or responses to therapeutics,” notes Justin Saeks, the report’s author. “The use of mass spectrometry has enabled the large-scale discovery of such molecules providing the both the diagnostics and pharmaceutical industries an opportunity for exceptional growth in the near term.”

Profiling the top suppliers of MS instrumentation, Mass Spectrometry for Protein Biomarker Applications provides a comprehensive market overview while reviewing the regulatory environment, surveying competing technologies, and detailing the extensive research collaborations occurring in the marketplace. It is available from Kalorama Information by clicking:

http://www.bioportfolio.com/cgi-bin/acatalog/Mass_Spectrometry_in_Protein_Biomarker_Applications_-_Software__Services__and_Instrument_Markets.html

About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent market research for the life sciences. To view their catalogue go to:

http://www.bioportfolio.com/cgi-bin/acatalog/Kalorama.html